An alkaloid derivative from Coscinium fenestratum exhibit dual COX/LOX inhibition

Authors

  • Shahid Adangam Purath School of Chemical Sciences, Swami Anandatheertha Campus, Kannur University, Kannur, Kerala, India, 670327
  • Sudheesh Sudhakaran School of Chemical Sciences, Swami Anandatheertha Campus, Kannur University, Kannur, Kerala, India, 670327
  • Karickal R Haridas School of Chemical Sciences, Swami Anandatheertha Campus, Kannur University, Kannur, Kerala, India, 670327.

DOI:

https://doi.org/10.56511/JIPBS.2018.v5.i01.pp117-121

Abstract

Agents that inhibit both Cyclooxygenase (COX) and Lipoxygenase (LOX) are highly recommended in the development of anti-inflammatory drugs. An alkaloid derivative from Coscinium fenestratum was isolated and characterized by UV Visible, IR, 1H NMR, 13C NMR and LC-MS spectroscopy. Dual COX/LOX inhibitory study was performed by high throughput screening assay. In the control (maximum enzyme activity) experiment COX activity of 73 µmol/min was noted, which is reduced to 50 µmol/min by the compound isolated. The standard inhibitors show 38 and 29 µmol/min respectively for Aspirin and Nimesulide. Compound isolated from Coscinium fenestratum also possess significant LOX inhibition when compared to standard inhibitor vanillin.

Keywords:

Coscinium fenestratum, Cyclooxygenase, Lipoxygenase, Aspirin, Nimesulide

Downloads

Download data is not yet available.

References

Ursula Weiss. Inflammation. Nature insight. 2008; 454(7203): 427 – 77.

Hawkey CJ: COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol 2001; 15(5):801 – 20.

Jackson LM, Hawkey CJ: COX-2 Selective Nonsteroidal AntiInflammatory Drugs Do They Really Offer Any Advantages ?. Drugs 2000; 59(6):1207 – 16.

Tushar KV, George S, Remashree AB, Balachandran I: Coscinium fenestratum (Gaertn.) Colebr.-A review on this rare, critically endangered and highly-traded medicinal species. Journal of Plant Sciences 2008; 3(2):133-45.

Subbaramaiah K, Dannenberg AJ: Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci. 2003; 24(2):96 – 102.

Lanza FL, Rack MF, Simon TJ, Quan H, Bolognese JA, Hoover ME, et al.: Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin of ibuprofen. Aliment Pharmacol Ther 1999; 13(6):761 – 7.

Ray W a, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR: COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002; 360:1071 – 3.

Dogné JM, Supuran CT, Pratico D: Adverse cardiovascular effects of the coxibs. J Med Chem [Internet]. 2005; 48(7):2251 – 2257. Available from: http://pubs.acs.org/doi/abs/10.1021/jm0402059

Poeckel D, Funk CD: The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease. Cardiovasc Res. 2010; 86(2):243 – 53.

Eswani N, Kudus K, Nazre M, Noor a. GA: Medicinal Plant Diversity and Vegetation Analysis of Logged over Hill Forest of Tekai Tembeling Forest Reserve, Jerantut, Pahang. J Agric Sci. 2010; 2(3):189 – 210.

Sudharshan S., Prashith Kekuda T., Sujatha M: Antiinflammatory activity of Curcuma aromatica Salisb and Coscinium fenestratum Colebr : A comparative study. J Pharm Res. 2010; 3(10):24 – 5.

Chitra K, Sujatha K, Polisetti H, Karri S, Umamaheswara Reddy C: Standardization of Coscinium fenestratum with reference to berberine by high performance thin layer chromatography. Res J Pharm Biol Chem Sci. 2011; 2(2):226 – 9.

Rai R V., Rajesh PS, Kim HM: Medicinal use of Coscinium fenestratum (Gaertn.) Colebr.: An short review. Orient Pharm Exp Med. 2013; 13(1):1 – 9.

Rojsanga P, Gritsanapan W, Suntornsuk L: Determination of berberine content in the stem extracts of Coscinium fenestratum by TLC densitometry. Med Princ Pract. 2006;15(5):373 – 8.

Ali SS, Kasoju N, Luthra A, Singh A, Sharanabasava H, Sahu A, et al.: Indian medicinal herbs as sources of antioxidants. Food Res Int. 2008; 41(1):1 – 15.

Pinho PMM, Pinto MMM, Kijjoa A, Pharadai K, Díaz JG, Herz W: Protoberberine alkaloids from Coscinium fenestratum. Phytochemistry 1992; 31(4):1403 – 7.

Anil Kumar K, Chandramohan Reddy T, Reddy G V., Bharat Kumar Reddy D, Mahipal SVK, Sinha S, et al.: High-throughput screening assays for cyclooxygenase-2 and 5-lipoxygenase, the targets for inflammatory disorders. Indian J Biochem Biophys. 2011; 48(4):256 – 61.

Anthon GE, Barrett DM: Thermal inactivation of lipoxygenase and hydroperoxytrienoic acid lyase in tomatoes. Food chemistry 2003; 81:275 – 9.

Tran Q Le, Tezuka Y, Ueda JY, Nguyen NT, Maruyama Y, Begum K, et al.: In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. J Ethnopharmacol. 2003; 86(2 – 3):249 – 52.

Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA [Internet]. 1999; 96(13):7563 – 8.

Published

05-01-2018
Statistics
215 Views | 247 Downloads

How to Cite

Shahid Adangam Purath, Sudheesh Sudhakaran, and Karickal R Haridas. “An Alkaloid Derivative from Coscinium Fenestratum Exhibit Dual COX/LOX Inhibition”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 5, no. 1, Jan. 2018, pp. 117-21, doi:10.56511/JIPBS.2018.v5.i01.pp117-121.

Issue

Section

Research Article